The high incidence and long latent period of prostate cancer make it an ideal target for chemoprevention. We have evaluated a series of agents for chemopreventive efficacy using a model in which hormone-dependent prostate cancers are induced in the Wistar-Unilever (WU) rat by sequential treatment with antiandrogen (cyproterone acetate), androgen (testosterone propionate), and direct-acting chemical carcinogen (N-methyl-N-nitrosourea), followed by chronic androgen stimulation (testosterone). This regimen reproducibly induces prostate cancers in high incidence, with no gross toxicity and a low incidence of neoplasia in the seminal vesicle and other non-target tissues. Dehydroepiandrosterone (DHEA) and 9-cis-retinoic acid (9-cis-RA) are the most active agents identified to date. DHEA inhibits prostate cancer induction both when chronic administration is begun prior to carcinogen exposure, and when administration is delayed until preneoplastic prostate lesions are present. 9-cis-RA is the most potent inhibitor of prostate carcinogenesis identified; a study to determine the efficacy of delayed administration of 9-cis-RA is in progress. Liarozole fumarate confers modest protection against prostate carcinogenesis, while N-(4-hydroxyphenyl)retinamide (fenretinide), α-difluoromethylornithine, oltipraz, DL-α-tocopherol acetate (vitamin E), and L-selenomethionine are inactive. Chemoprevention efficacy evaluations in the WU rat will support the identification of agents that merit study for prostate cancer chemoprevention in humans.

Keywords:
Prostate cancer, Chemoprevention, Dehydroepiandrosterone, 9-cis-Retinoic acid, α-Difluoromethylornithine, L-Selenomethionine, DL-α-Tocopherol (vitamin E), Liarozole fumarate, N-(4-Hydroxyphenyl)retinamide (fenretinide), Oltipraz
1.
Landis SH, Murray T, Bolden S, Wingo PA: Cancer statistics, 1998. CA Cancer J Clin 1998;48:6–29.
2.
Lalani el-N, Laniado ME, Abel PD: Molecular and cellular biology of prostate cancer. Cancer Metastasis Rev 1996;16:29–66.
3.
Nelson PS, Gleason TP, Brawer MK: Chemoprevention for prostatic intraepithelial neoplasia. Eur Urol 1996;30:269–278.
4.
Bostwick DG: Prospective origins of prostate carcinoma. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Cancer 1996;78:330–336.
5.
Bosland MC, Prinsen MK: Induction of dorsolateral prostate adenocarcinomas and other accessory sex gland lesions in male Wistar rats by a single administration of N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2′-dimethyl-4-aminobiphenyl after sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res 1990;50:691–699.
6.
Bosland MC, Prinsen MK, Dirksen TJM, Spit BJ: Characterization of adenocarcinomas of the dorsolateral prostate induced in Wistar rats by N-methyl-N-nitrosourea, 7,12-dimethylbenz(a)anthracene, and 3,2′-dimethyl- 4-aminobiphenyl, following sequential treatment with cyproterone acetate and testosterone propionate. Cancer Res 1990;50:700–709.
7.
McCormick DL, Rao KVN, Dooley L, Lubet RA, Steele VE, Kelloff GJ, Bosland MC: Influence of N-methyl-N-nitrosourea, testosterone, and N-(4-hydroxyphenyl)-all-trans-retinamide on prostate cancer induction in Wistar (WU) rats. Cancer Res 1998;58:3282–3288.
8.
Bosland MC: Age-related lesions in the male accessory sex glands and penis of the rat; in Mohr U, et al (eds): Monographs on Pathology of the Aging Rat. Washington, ILSI Press, 1992, vol 1, pp 443–467.
9.
McCormick DL, Rao KVN, Steele VE, Lubet RA, Kelloff GJ, Bosland MC: Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid. Cancer Res 1999;59:521–524.
10.
McCormick DL, Rao KVN, Bosland MC, Steele VE, Lubet RA, Kelloff GJ: Inhibition of rat prostatic carcinogenesis by dietary dehydroepiandrosterone but not by N-(4-hydroxyphenyl)-all-trans-retinamide. Proc Am Assoc Cancer Res 1995;36:126.
11.
Rao KVN, Bosland MC, Lubet RA, Steele VE, Kelloff GJ, McCormick DL: Inhibition of rat prostate carcinogenesis by delayed administration of dehydroepiandrosterone. Proc Am Assoc Cancer Res 1997;38:580.
12.
McCormick DL, Rao KVN, Johnson WD, Bowman-Gram TA, Steele VE, Lubet RA, Kelloff GJ: Exceptional chemopreventive activity of low dose dehydroepiandrosterone in the rat mammary gland. Cancer Res 1996;56:1724–1726.
13.
Rao KVN, McCormick DL, Bosland MC, Steele VE, Lubet RA, Kelloff GJ: Chemopreventive efficacy evaluation of liarozole fumarate, difluoromethylornithine, and oltipraz in the rat prostate. Proc Am Assoc Cancer Res 1996;37:273.
14.
McCormick DL, Rao KVN, Lubet RA, Steele VE, Kelloff GJ, Bosland MC: Differential activity of 9-cis-retinoic acid, α-tocopherol, and selenomethionine as chemopreventive agents in the rat prostate. Proc Am Assoc Cancer Res 1997;38:261.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.